Clinical Trials Browser

Phase 2 × INDUSTRY × PM 00104 × Clear all

NCT01222767 2021-10-29

Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy

Phase 2 Completed

17 enrolled 20 charts

Sarcoma, Ewing, Neuroectodermal Tumors, Primitive

NCT00900562 2021-10-28

Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy

Phase 2 Terminated

19 enrolled 21 charts

Uterine Cervical Neoplasms, Neoplasms, Endometrial Neoplasms